GlassScriptPhysician profile
Ruyu Qin
NPI 1184497281
$3,116.20
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,960 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,865 · Travel and Lodging: $1,089 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,865.15 |
| Travel and Lodging | $1,089.07 |
| Education | $161.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,105.62 | 2024 | Inspire |
| Harmony Biosciences LLC | $499.71 | 2024 | |
| Genzyme Corporation | $240.56 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $228.45 | 2024 | Tezspire, Airsupra, Fasenra |
| Mallinckrodt Hospital Products INC. | $176.81 | 2024 | Acthar |
| Jazz Pharmaceuticals INC. | $170.26 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $149.54 | 2024 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $140.63 | 2024 | Lumryz |
| Philips North America LLC | $91.21 | 2024 | (Ak6) Vest Therapy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.36 | 2024 | Stiolto Respimat |
| Amgen INC. | $63.30 | 2024 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $41.59 | 2024 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $40.98 | 2024 | Nucala |
| Mylan Specialty L.P. | $35.62 | 2024 | Yupelri |
| Convatec INC. | $32.96 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $32.60 | 2024 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruyu Qin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.